IRCSX | ISCWX | IRCSX / ISCWX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 9 years | 17 years | - |
Gain YTD | 0.513 | 2.764 | 19% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000 | 1000 | 500% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.07B | 291M | 368% |
Annual Yield % from dividends | 2.58 | 1.40 | 184% |
Returns for 1 year | 11.18 | 10.98 | 102% |
Returns for 3 years | 1.37 | 7.57 | 18% |
Returns for 5 years | 14.60 | 24.42 | 60% |
Returns for 10 years | N/A | 60.83 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EEMIX | 8.01 | 0.02 | +0.25% |
MFS Emerging Markets Equity Research I | |||
JFNSX | 65.68 | 0.01 | +0.02% |
Janus Henderson Global Life Sciences S | |||
VWYFX | 45.24 | N/A | N/A |
Voya Small Cap Growth A | |||
PECAX | 17.11 | -0.09 | -0.52% |
JPMorgan SMID Cap Equity A | |||
EKGIX | 39.64 | -0.34 | -0.85% |
Allspring Special Global Small Cap Inst |